M3-BRIGADE ACQUISITION V-A (MBAV) Fundamental Analysis & Valuation

NASDAQ:MBAV • KYG632121078

Current stock price

10.7003 USD
+0.03 (+0.28%)
Last:

This MBAV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MBAV Profitability Analysis

1.1 Basic Checks

  • In the past year MBAV was profitable.
  • MBAV had a negative operating cash flow in the past year.
MBAV Yearly Net Income VS EBIT VS OCF VS FCFMBAV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 2M -2M 4M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA 1.88%
ROE 2.01%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBAV Yearly ROA, ROE, ROICMBAV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 1 -1 2

1.3 Margins

  • MBAV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBAV Yearly Profit, Operating, Gross MarginsMBAV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MBAV Health Analysis

2.1 Basic Checks

  • MBAV has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, MBAV has a worse debt to assets ratio.
MBAV Yearly Shares OutstandingMBAV Yearly Shares OutstandingYearly Shares Outstanding 2024 2025 10M 20M 30M
MBAV Yearly Total Debt VS Total AssetsMBAV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 2025 100M 200M 300M

2.2 Solvency

  • MBAV has an Altman-Z score of 10.94. This indicates that MBAV is financially healthy and has little risk of bankruptcy at the moment.
  • A Debt/Equity ratio of 0.01 indicates that MBAV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 10.94
ROIC/WACCN/A
WACCN/A
MBAV Yearly LT Debt VS Equity VS FCFMBAV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • MBAV has a Current Ratio of 0.18. This is a bad value and indicates that MBAV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MBAV has a Quick Ratio of 0.18. This is a bad value and indicates that MBAV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
MBAV Yearly Current Assets VS Current LiabilitesMBAV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MBAV Growth Analysis

3.1 Past

  • MBAV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.59%, which is quite good.
EPS 1Y (TTM)10.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. MBAV Valuation Analysis

4.1 Price/Earnings Ratio

  • MBAV is valuated quite expensively with a Price/Earnings ratio of 66.88.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, MBAV is valued quite expensively.
Industry RankSector Rank
PE 66.88
Fwd PE N/A
MBAV Price Earnings VS Forward Price EarningsMBAV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBAV Per share dataMBAV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MBAV Dividend Analysis

5.1 Amount

  • MBAV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MBAV Fundamentals: All Metrics, Ratios and Statistics

M3-BRIGADE ACQUISITION V-A

NASDAQ:MBAV (3/23/2026, 12:38:23 PM)

10.7003

+0.03 (+0.28%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners96.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change45.36%
Market Cap384.57M
Revenue(TTM)N/A
Net Income(TTM)5.78M
AnalystsN/A
Price TargetN/A
Short Float %0.46%
Short Ratio1.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 66.88
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)0.16
EY1.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS8
TBVpS8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.37
Profitability
Industry RankSector Rank
ROA 1.88%
ROE 2.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z 10.94
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1330.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-191.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-191.41%
OCF growth 3YN/A
OCF growth 5YN/A

M3-BRIGADE ACQUISITION V-A / MBAV Fundamental Analysis FAQ

What is the fundamental rating for MBAV stock?

ChartMill assigns a fundamental rating of 1 / 10 to MBAV.


What is the valuation status for MBAV stock?

ChartMill assigns a valuation rating of 0 / 10 to M3-BRIGADE ACQUISITION V-A (MBAV). This can be considered as Overvalued.


What is the profitability of MBAV stock?

M3-BRIGADE ACQUISITION V-A (MBAV) has a profitability rating of 0 / 10.


What is the valuation of M3-BRIGADE ACQUISITION V-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for M3-BRIGADE ACQUISITION V-A (MBAV) is 66.88 and the Price/Book (PB) ratio is 1.34.